TIL (STOCKS)
Instil Bio, Inc. Common Stock
$8.190000
+0.080000 (+0.99%)
Prev close: $8.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bronson Crouch
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $57.51M
- Employees
- 14
- P/E (TTM)
- -0.78
- P/B (TTM)
- 0.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
3
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.21 | $-2.05 | +0.8369 | +40.89% |
|
Sep 2025 (Q3)
|
$-2.01 | $-2.38 | +0.3686 | +15.50% |
|
Jun 2025 (Q2)
|
$-3.24 | $-2.53 | -0.7125 | -28.19% |
|
Mar 2025 (Q1)
|
$-4.32 | $-2.61 | -1.7071 | -65.33% |
Financial Statements
| Revenues | $972.52K |
| Benefits Costs and Expenses | $2.34M |
| Costs And Expenses | $2.34M |
| Operating Expenses | $2.34M |
| Operating Income/Loss | -$1.37M |
| Income/Loss Before Equity Method Investments | -$1.37M |
| Income/Loss From Continuing Operations After Tax | -$1.58M |
| Income/Loss From Continuing Operations Before Tax | -$1.58M |
| Income/Loss From Discontinued Operations Net Of Tax | -$2.25M |
| Income/Loss From Equity Method Investments | -$84.18K |
| Income Tax Expense/Benefit | $128.97K |
| Net Income/Loss | -$3.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$91.17K |
| Net Income/Loss Attributable To Parent | -$3.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $73.50M |
| Current Assets | $73.50M |
| Noncurrent Assets | $0.00 |
| Fixed Assets | $22.36K |
| Liabilities | $51.50M |
| Current Liabilities | $51.50M |
| Noncurrent Liabilities | $0.00 |
| Equity | $22.00M |
| Equity Attributable To Noncontrolling Interest | $59.53K |
| Equity Attributable To Parent | $21.94M |
| Liabilities And Equity | $73.50M |
| Net Cash Flow From Operating Activities | -$3.87M |
| Net Cash Flow From Operating Activities, Continuing | -$1.64M |
| Net Cash Flow From Operating Activities, Discontinued | -$2.23M |
| Net Cash Flow From Investing Activities | $4.59M |
| Net Cash Flow From Investing Activities, Continuing | $2.26M |
| Net Cash Flow From Investing Activities, Discontinued | $2.33M |
| Net Cash Flow From Financing Activities | $3.01M |
| Net Cash Flow From Financing Activities, Continuing | $3.01M |
| Exchange Gains/Losses | $501.68K |
| Net Cash Flow | $3.73M |
| Net Cash Flow, Continuing | $3.57M |
| Net Cash Flow, Discontinued | -$349.49K |
| Comprehensive Income/Loss | -$3.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.74M |
| Other Comprehensive Income/Loss | $86.08K |